The most commonly studied methylation biomarkers in ctDNA from lung cancer patients are SHOX2, RASSF1A, RARB, LINE-1, PCDKN2A, MGMT, DAPK, APC, and DLEC1 [109]. This evidence concerns the gene SHOX2 and lung carcinoma.